From Geert: The author of this article lacks a basic understanding of how our immune system fights off acute, self-limiting diseases. They are so obsessed with intervening in the immune system that they have completely forgotten about the crucial role of our first line of defense, the innate immune system. They have no understanding that the cell-based innate immune system can be strengthened by exposure to several different viruses causing acute, self-limiting diseases. Don't they realize that this type of immune defense is virus-nonspecific and that exposure to SARS-CoV-2 also strengthens our first line of defense against other respiratory diseases? Have they never wondered why childhood vaccines, all of which are live attenuated, are so successful that they have never been replaced by "modern" vaccines, such as those using subunit or recombinant vaccine technologies? For many months, people have not been respecting social distancing, wearing masks, or adhering to other infection-prevention measures. For many months, circulating variants have been highly infectious. Nevertheless, this author has cherry-picked some cheap data to make people believe that precisely these measures, at a time when they are no longer respected, have caused reduced transmission of highly transmissible circulating variants and this is now responsible for an "immunity gap" and promoting the occurrence of other infectious diseases.
Of course, this must be true, as even mathematical modeling, which we all know fails miserably over and over again due to uninformed assumptions, has proven this! How can this immunity gap be more pronounced in babies and children? Aren't they immunologically naïve anyway? The author is even invoking the hygiene theory and suggesting that the sterile environment generated by the no longer existing infection-prevention measures are causing a lack of exposure. What the author seems to be unaware of is that the bulk of other respiratory diseases consists of RSV and flu infections. It is unlikely that this juvenile author has any understanding of how highly activated cytolytic T cells enable C-19 vaccinees to spread RSV and influenza asymptomatically, whereas both infections usually cause symptoms. This has to do with CTL-mediated targeting of a shared (‘universal’) T cell peptide in host cells infected by these enveloped glycosylated viruses. Asymptomatic shedding of RSV and influenza by C-19 vaccinees is causing high infectious pressure in highly vaccinated countries. It is therefore not surprising that those who are immunologically naïve (children are typically not vaccinated against RSV or flu for different reasons) and not equipped with C-19 activated CTLs have a higher chance of being infected because of enhanced exposure! The surge of respiratory infections in immunologically naïve individuals is therefore to be considered a direct consequence of a high rate of C-19 vaccination and not a lack of exposure. As I have predicted, these waves will calm down as natural immunity in babies and children will be strengthened and ultimately protect them from disease. Although C-19 vaccination provides temporary relief from these diseases, this protection is temporary and very fragile. The unbelievers can read my upcoming book or wait and see. In addition, C-19 vaccination sidelines the cell-based innate immune system, which is key to enabling full-fledged natural immunity against a multitude of other acute, self-limiting viral infections.
This is yet another example of how blatant immunological illiteracy drives young and inexperienced scientists (https://www.ibt.unam.mx/perfil/4311/mc-alicia-helena-marquez-bandala) to swallow the narrative and erroneously advise parents to vaccinate their young children:
“In the case of COVID-19, it is not planned to vaccinate children under 5 years of age, and if we do not vaccinate children under 5 years of age, that gap will exist. In addition, this winter season will be important to know whether we are already endemic or not”.
Not having any relevant immunological insight and blindly citing other scientists who believe that endemicity is still within reach speaks volumes about the value of this article. We have no choice but to continue destroying this simplistic but dangerous line of reasoning.
“The Massachusetts cases are the first confirmed in the lab to have developed the ability to sidestep six of the seven drugs that health authorities track for potential resistance. It carries a change to the "penA60 allele" – a gene mutation – which has been linked to previous ceftriaxone-resistant cases in Nevada, the United Kingdom, and Asia.”
“It’s absurd. Someone dies and we can’t even accurately write the cause,” the 23-year-old said, asking to be identified only by her surname.
“considering the extensive herd immunity built up in the population over the last three years from infections and vaccinations.”
From Geert: “This publication illustrates once more the immunological illiteracy of mutation spotters who continue to make people believe that the population has established herd immunity! They are confusing population-level immune PRESSURE (‘herd immune pressure’) on the virus with herd immunity! No population establishing herd immunity breeds immune escape variants that dominantly (co-)circulate! An immune escape pandemic can never generate herd immunity and vice versa! This is a contradictio in terminis! Their immunological ignorance is an insult to the science.”
“Government also prepares to launch emergency surge vaccinations if novel variant of sufficient concern emerges”
“In the October 2022 version of the FAA Guide for Aviation Medical Examiners, the FAA quietly widened the EKG parameters beyond the normal range (from a PR max of .2 to unlimited). And they didn’t widen the range by a little. They widened it by a lot. It was done after the vaccine rollout.”
"Unexplained" significant decline in fertility exactly 9 months after the start of the vaccination campaign.
Geert Vanden Bossche received his DVM from the University of Ghent, Belgium, and his PhD degree in Virology from the University of Hohenheim, Germany. He held adjunct faculty appointments at universities in Belgium and Germany. After his career in Academia, Geert joined several vaccine companies (GSK Biologicals, Novartis Vaccines, Solvay Biologicals) to serve various roles in vaccine R&D as well as in late vaccine development.
Geert then moved on to join the Bill & Melinda Gates Foundation’s Global Health Discovery team in Seattle (USA) as Senior Program Officer; he then worked with the Global Alliance for Vaccines and Immunization (GAVI) in Geneva as Senior Ebola Program Manager. At GAVI he tracked efforts to develop an Ebola vaccine. He also represented GAVI in fora with other partners, including WHO, to review progress on the fight against Ebola and to build plans for global pandemic preparedness.
Back in 2015, Geert scrutinized and questioned the safety of the Ebola vaccine that was used in ring vaccination trials conducted by WHO in Guinea. His critical scientific analysis and report on the data published by WHO in the Lancet in 2015 was sent to all international health and regulatory authorities involved in the Ebola vaccination program. After working for GAVI, Geert joined the German Center for Infection Research in Cologne as Head of the Vaccine Development Office. He is at present primarily serving as a Biotech / Vaccine consultant while also conducting his own research on Natural Killer cell-based vaccines.